- 专利标题： New Therapy for Transthyretin-Associated Amyloidosis
-
申请号： US15448054申请日： 2017-03-02
-
公开(公告)号： US20170304243A1公开(公告)日： 2017-10-26
- 发明人: Marc Centellas Casado , Raúl Insa Boronat , Nuria Reig Bolano , Núria Gavaldà Batalla
- 申请人： SOM INNOVATION BIOTECH, S.L.
- 优先权： EP11382326.4 20111024
- 主分类号： A61K31/198
- IPC分类号： A61K31/198 ; A61K31/603 ; A61K31/423 ; A61K31/353 ; A61K31/192 ; A61K45/06 ; A61K31/12
摘要：
It is provided a catechol-O-methyltransferase (COMT) inhibitor for use in the prevention and/or treatment of transthyretin-associated amyloidosis. It is also provided a catechol-O-methyltransferase (COMT) inhibitor for use in the prevention and/or treatment of transthyretin-associated amyloidosis in combination therapy with another COMT inhibitor, a benzoxazole derivative, iododiflunisal, diflunisal, resveratrol, tauroursodeoxycholic acid, doxocycline, or epigallocatechin-3-gallate.
公开/授权文献
- US10045956B2 Therapy for transthyretin-associated amyloidosis 公开/授权日：2018-08-14
信息查询
IPC分类:
